Patient Choice and Competition in Healthcare Markets

Patient choice and competition in healthcare markets examine how enabling individuals to select among providers, coupled with market‐style incentives, influences the performance, quality and equity of health systems. In theory, competition drives providers to improve efficiency and patient‐centred care, while choice empowers users to seek higher quality or more convenient services. In practice, realised benefits depend on the availability of reliable information, the degree of market contestability and regulatory design. Empirical studies highlight that competition can reduce waiting times and foster innovation in service delivery, yet it may also exacerbate disparities if better‐informed or more affluent patients disproportionately benefit. The balance between provider autonomy, performance measurement and equitable access remains central to ongoing policy reforms across diverse systems, from national health services to mixed public–private markets. Recent analyses emphasise the need to align incentives with patient outcomes, monitor unintended geographic and socioeconomic consequences and ensure transparent performance data to support genuine choice.

Research from Nature Portfolio

No recent Nature Portfolio content available.

Patient Choice and Competition in Healthcare Markets publication trend

The graph below shows the total number of articles in patient choice and competition in healthcare markets across all publications each year (not limited to Nature Index journals).

Technical terms

Patient mobility: The degree to which patients seek treatment at providers other than their nearest or default facility, reflecting active choice.

Spare capacity: The difference between a provider’s maximum potential service volume and its current utilisation, indicating untapped resources.

Treatable mortality: Deaths from conditions that should not occur in the presence of timely and effective healthcare interventions.

Market contestability: The ease with which new providers can enter or exit a market, influencing competitive pressure and innovation.

References

1. Managing the cancer backlog: a national population-based study of patient mobility, waiting times and ‘spare capacity’ for cancer surgery. The Lancet Regional Health - Europe (2023).
2. Association of Quality and Technology With Patient Mobility for Colorectal Cancer Surgery. JAMA Surgery (2023).
3. Outsourcing health-care services to the private sector and treatable mortality rates in England, 2013–20: an observational study of NHS privatisation. The Lancet Public Health (2022).
4. Behavioural determinants of the healthcare providers in Ukraine: Focus on competition context. Cleaner and Responsible Consumption (2024).